Related Experiment Video

Updated: Jul 19, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints

V Mamidipudi1, N K Dhillon, T Parman

  • 1Department of Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.

Oncogene
|October 31, 2006
PubMed

Insights

RACK1 protein suppresses colon cancer cell growth by inhibiting Src kinase activity at key cell cycle checkpoints. This discovery offers a potential new therapeutic strategy for colon cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Src tyrosine kinases are activated in early human colon cancer and decrease during intestinal cell differentiation.
  • RACK1 acts as a binding partner, substrate, and inhibitor of Src kinase.

Purpose of the Study:

  • To investigate the role of RACK1 in regulating colon cell growth by modulating Src activity.
  • To elucidate the mechanisms by which RACK1 influences cell cycle progression at G1 and mitotic checkpoints.

Main Methods:

  • Overexpression and depletion of RACK1 and Src.
  • Use of cell-permeable peptides to disrupt RACK1-Src interaction.
  • Analysis of cell cycle progression, HT-29 cell growth, and molecular targets (Sam68 phosphorylation, CDK1-cyclin B complex).

Main Results:

  • RACK1 suppresses colon cell growth by inhibiting Src activity at G1 and mitotic checkpoints, delaying cell cycle progression.
  • Activated Src can overcome RACK1-mediated growth inhibition in HT-29 cells.
  • Src inhibition counteracts growth promotion from RACK1 depletion in normal cells.
  • RACK1 regulates mitotic exit by suppressing Src-mediated Sam68 phosphorylation and maintaining active CDK1-cyclin B complex.

Conclusions:

  • RACK1 plays a critical role in controlling colon cell cycle progression at G1 and during mitosis.
  • RACK1's suppression of oncogenic Src kinase at cell cycle checkpoints provides a novel mechanism for slowing colon cancer growth.
  • RACK1-mimicking small molecules represent a promising therapeutic avenue for colon cancer treatment.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...